top of page

SIGNIFOR LAR POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION 20MG

Product details

Registration number: SIN15168P

Classification: Prescription Only

Active ingredients: Pasireotide pamoate 27.42mg eqv Pasireotide

Strength: 20mg

Dosage form: INJECTION, POWDER, FOR SUSPENSION

Route: INTRAMUSCULAR

Registrant: PHARM-D SINGAPORE PRIVATE LIMITED

ATC code: H01CB05

HSA approval date: 2 February 2017

Manufacturer(s):

  • Novartis Pharmaceutical Manufacturing GmbH (primary packager of Powder)
  • Abbott Biologicals B.V. (manufacture, primary and secondary packager for solvent)
  • Synergy Health Daniken AG (sterilization site)
  • Recordati AG Rare Diseases Branch (manufacture of bulk powder)

Manufacturing country/countries: SWITZERLAND; AUSTRIA; NETHERLANDS

What are the HSA registration number and classification for SIGNIFOR LAR POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION 20MG?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN15168P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for SIGNIFOR LAR POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION 20MG?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Pasireotide pamoate 27.42mg eqv Pasireotide

Strength: 20mg

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for SIGNIFOR LAR POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION 20MG?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION, POWDER, FOR SUSPENSION

Route: INTRAMUSCULAR

Source for this answer

Who is the recorded registrant for SIGNIFOR LAR POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION 20MG?

According to the HSA dataset updated 7 August 2026:

Registrant: PHARM-D SINGAPORE PRIVATE LIMITED

Source for this answer

Which manufacturers and countries are listed for SIGNIFOR LAR POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION 20MG?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • Novartis Pharmaceutical Manufacturing GmbH (primary packager of Powder)
  • Abbott Biologicals B.V. (manufacture, primary and secondary packager for solvent)
  • Synergy Health Daniken AG (sterilization site)
  • Recordati AG Rare Diseases Branch (manufacture of bulk powder)

Manufacturing country/countries: SWITZERLAND; AUSTRIA; NETHERLANDS

Source for this answer

Where can I look up SIGNIFOR LAR POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION 20MG in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN15168P or the exact product name SIGNIFOR LAR POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION 20MG. The general register link does not preselect this product.

Source for this answer

What are the source dates for this SIGNIFOR LAR POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION 20MG record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this SIGNIFOR LAR POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION 20MG record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN15168P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page